Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China

Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China

PurposeDipeptidylpeptidase-4 (DPP-4) inhibitors, including linagliptin, alogliptin, saxagliptin, sitagliptin, and vildagliptin, are used for the treatment of type 2 diabetes mellitus (T2DM) patients in China. This study assessed the economic outcomes of different DPP-4 inhibitors in patients with T2...

Full description

Bibliographic Details
Main Authors:	Wen-Qiang Lin, Zhong-jie Cai, Tingting Chen, Mao-Bai Liu, Na Li, Bin Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Endocrinology
Subjects:	dipeptidylpeptidase-4 inhibitors cost-effectiveness type 2 diabetes mellitus incremental cost-effectiveness ratio quality-adjusted life-year
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.684960/full

Similar Items

Dipeptidylpeptidase-4 inhibitors in the treatment of diabetes mellitus. Possibilities of cardioprotection
by: Elena Nikolaevna Trunina, et al.
Published: (2011-06-01)

Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China
by: Xingyun Hou, et al.
Published: (2019-05-01)

Hypoglycemia Associated With Drug–Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors
by: Chin-Ying Ray, et al.
Published: (2021-04-01)

Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective
by: Timo Purmonen, et al.
Published: (2018-11-01)

Cost-Effectiveness of Vitamin D Supplementation in Pregnant Woman and Young Children in Preventing Rickets: A Modeling Study
by: Vilius Floreskul, et al.
Published: (2020-09-01)

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
by: Makoto Shiragami, et al.
Published: (2019-03-01)

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK
by: Zalmai Hakimi, et al.
Published: (2018-01-01)

Cost-effectiveness analysis of tele-retinopathy of prematurity screening in Iran
by: Seyed-Farzad Mohammadi, et al.
Published: (2021-04-01)

Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review
by: Resign Gunda, et al.
Published: (2017-07-01)

Dipeptidylpeptidase-IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats
by: E. Tarantola, et al.
Published: (2012-10-01)

A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan
by: Akazawa M, et al.
Published: (2019-09-01)

Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom
by: Gabriel Tremblay, et al.
Published: (2018-10-01)

Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review
by: Cristian Eduardo Navarro, et al.
Published: (2020-03-01)

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021-02-01)

Cost–Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study)
by: Adrián Pérez-Aranda, et al.
Published: (2019-07-01)

Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes
by: Christina S. Kwon, et al.
Published: (2018-02-01)

Dipeptidylpeptidase-IV activity and expression reveal decreased damage to the intrahepatic biliary tree in fatty livers submitted to subnormothermic machine-perfusion respect to conventional cold storage
by: E. Tarantola, et al.
Published: (2014-07-01)

Actions and antidiabetic potential of amino terminally modified analogues of glucose dependent insulinotropic polypeptide
by: Gault, Victor Alan
Published: (2001)

Cost Effectiveness Analysis Using Disability-Adjusted Life Years for Cataract Surgery
by: Thinni Nurul Rochmah, et al.
Published: (2020-08-01)

Sequencing Systemic Therapy Pathways for Advanced Hepatocellular Carcinoma: A Cost Effectiveness Analysis
by: Christopher Sherrow, et al.
Published: (2020-08-01)

Cost effectiveness of pre-referral antimalarial treatment in severe malaria among children in sub-Saharan Africa
by: Vivian Rakuomi, et al.
Published: (2017-07-01)

No differences in cost-effectiveness and short-term functional outcomes between cemented and uncemented total knee arthroplasty
by: R. Rassir, et al.
Published: (2020-07-01)

Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society
by: Stig Evensen, et al.
Published: (2019-05-01)

Cost-effectiveness analysis of the integrated control strategy for schistosomiasis japonica in a lake region of China: a case study
by: Ling-Ling Wu, et al.
Published: (2021-05-01)

Considering the societal perspective in economic evaluations: a systematic review in the case of depression
by: Juliane Andrea Duevel, et al.
Published: (2020-09-01)

Cost-Effectiveness of the Interventions to Avoid Complications and Management in Diabetes Mellitus: A Narrative Review from South-East Asian Perspective
by: Jamshed Shazia Qasim, et al.
Published: (2018-06-01)

Experiences of including costs of added life years in health economic evaluations in Sweden
by: Laura Pirhonen, et al.
Published: (2014-06-01)

Automatic Assessment of Socioeconomic Impact on Cardiac Rehabilitation
by: Mireia Calvo, et al.
Published: (2013-10-01)

Blood pressure telemonitoring and remote counseling in uncontrolled hypertension
by: Mikhail V. Ionov, et al.
Published: (2021-01-01)

Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
by: Mezones Holguín, Edward, et al.
Published: (2015)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
by: Michal Pochopien, et al.
Published: (2019-01-01)

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies
by: T. S. Teptsova, et al.
Published: (2018-11-01)

Cost-effectiveness and feasibility of conditional economic incentives and motivational interviewing to improve HIV health outcomes of adolescents living with HIV in Anambra State, Nigeria
by: Obinna Ikechukwu Ekwunife, et al.
Published: (2021-07-01)

Cost effectiveness of cancer treatment in Taiwan
by: Mei-Chuan Hung, et al.
Published: (2016-08-01)

Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients
by: Puspitasari IM, et al.
Published: (2021-02-01)

An Assessment of the U.S. Army Corps of Engineers' Environmental Plan Evaluation Methods
by: Holland, Michael
Published: (2011)

Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand
by: Permsuwan U, et al.
Published: (2020-10-01)

An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran
by: Najmeh Moradi, et al.
Published: (2020-10-01)

Health–economic benefits of treating trauma in psychosis
by: Paul A. J. M. de Bont, et al.
Published: (2019-12-01)

Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab
by: Yifan Xu, et al.
Published: (2018-11-01)

Cannot write session to /tmp/vufind_sessions/sess_icbr4r3s79oc0qg2f3bs9342ek